ALPS ADVISORS INC - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 112 filers reported holding ALBIREO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$303,793
+46.1%
14,058
+30.8%
0.00%
+50.0%
Q3 2022$208,000
-10.0%
10,748
-7.4%
0.00%0.0%
Q2 2022$231,000
-61.1%
11,612
-41.6%
0.00%
-66.7%
Q1 2022$594,000
+14.2%
19,900
-10.8%
0.01%0.0%
Q4 2021$520,000
-29.3%
22,307
-5.5%
0.01%
-14.3%
Q3 2021$736,000
-17.2%
23,595
-6.6%
0.01%
-12.5%
Q2 2021$889,000
-27.1%
25,275
-26.9%
0.01%
-33.3%
Q1 2021$1,219,000
-5.4%
34,581
+0.7%
0.01%
-20.0%
Q4 2020$1,288,000
+59.4%
34,325
+41.8%
0.02%
+25.0%
Q3 2020$808,000
+49.4%
24,215
+18.5%
0.01%
+71.4%
Q2 2020$541,000
+24.7%
20,432
-23.0%
0.01%0.0%
Q1 2020$434,000
-33.7%
26,527
+3.0%
0.01%
+40.0%
Q4 2019$655,000
+29.2%
25,756
+1.6%
0.01%
+25.0%
Q3 2019$507,000
-37.6%
25,338
+0.6%
0.00%
-33.3%
Q2 2019$812,000
-12.8%
25,190
-12.9%
0.01%
-14.3%
Q1 2019$931,000
+37.3%
28,912
+4.5%
0.01%
+40.0%
Q4 2018$678,000
-2.9%
27,659
+30.6%
0.01%0.0%
Q3 2018$698,000
+13.9%
21,181
+22.7%
0.01%
+25.0%
Q2 2018$613,00017,2570.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Prosight Management, LP 514,082$11,973,0007.17%
Privium Fund Management B.V. 379,117$8,959,0001.78%
Birchview Capital, LP 113,000$2,632,0001.70%
Sio Capital Management, LLC 213,913$4,982,0001.50%
Perceptive Advisors 4,720,278$109,936,0000.85%
Chicago Capital, LLC 849,239$19,779,0000.74%
APOGEM CAPITAL LLC 38,601$899,0000.59%
Samsara BioCapital, LLC 100,000$2,329,0000.45%
Artal Group S.A. 600,000$13,974,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 458,011$10,667,0000.38%
View complete list of ALBIREO PHARMA INC shareholders